Cargando…
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge model
Imiquimod (IMQ) is a topical agent that induces local inflammation via the Toll-like receptor 7 pathway. Recently, an IMQ-driven skin inflammation model was developed in healthy volunteers for proof-of-pharmacology trials. The aim of this study was to profile the cellular, biochemical, and clinical...
Autores principales: | Assil, Salma, Buters, Thomas P., Hameeteman, Pieter W., Hallard, Charlie, Treijtel, Nicoline, Niemeyer – Van der Kolk, Tessa, de Kam, Marieke L., Florencia, Edwin F. I. I. I., Prens, Errol P., van Doorn, Martijn B. A., Rissmann, Robert, Klarenbeek, Naomi B., Jansen, Manon A. A., Moerland, Matthijs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400434/ https://www.ncbi.nlm.nih.gov/pubmed/37545524 http://dx.doi.org/10.3389/fimmu.2023.1197650 |
Ejemplares similares
-
Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers
por: Niemeyer‐van der Kolk, Tessa, et al.
Publicado: (2020) -
Comprehensive, Multimodal Characterization of an Imiquimod‐Induced Human Skin Inflammation Model for Drug Development
por: van der Kolk, Tessa, et al.
Publicado: (2018) -
Blueprint for mechanistic, data‐rich early phase clinical pharmacology studies in dermatology
por: Rissmann, Robert, et al.
Publicado: (2020) -
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers
por: Buters, Thomas P., et al.
Publicado: (2022) -
Complement Activation in Inflammatory Skin Diseases
por: Giang, Jenny, et al.
Publicado: (2018)